Aqua Medical Announces Final $8.2 Million Equity Investment Led by ShangBay Capital to Close Its $15.5 Million Series A Financing Round
Sep 01, 2020•about 5 years ago
Amount Raised
$8 Million
Round Type
series a
Description
Aqua Medical's innovative platform technology provides endoscopic non-surgical, outpatient ablation treatment of multiple sites throughout the gastrointestinal (GI) tract with its new Radio Frequency Vapor Ablation (RFVA) system.